Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4621 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Ford government cuts to children's mental health and autism services cause 21 layoffs at Maltby Centre

Read more ››
By: PR Newswire Association LLC. - 21 Mar 2024

2024 outlook and pro forma financials

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Novozymes A/S

CMR Surgical announces over 20,000 surgical cases completed using Versius

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  CMR Surgical Ltd.

Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Angelini Ventures

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Fennec Pharmaceuticals Inc.

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder

Read more ››
By: GlobeNewswire - 21 Mar 2024

X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  X4 Pharmaceuticals, Inc.

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Affimed N.V

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Agile Therapeutics, Inc.

Castellum, Inc. Announces 2023 Financial Results

Read more ››
By: GlobeNewswire - 21 Mar 2024

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Mineralys Therapeutics, Inc.

Chimerix Appoints Marc D. Kozin to Board of Directors

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Chimerix, Inc.

InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  InflaRx N.V.

Immatics Announces Full Year 2023 Financial Results and Corporate Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Immatics N.V.

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Bavarian Nordic A/S

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  TELA Bio, Inc

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  MediWound Ltd.

OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  OKYO Pharma Limited

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Pluri Inc.

Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum

Read more ››
By: GlobeNewswire - 21 Mar 2024
Related companies:  Gyre Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑